Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

ACTIVE NOT RECRUITING NA

Addressing Financial and Social Needs Among Patients With Cancer

NCT06430840 · View on ClinicalTrials.gov ↗

Study Summary

Financial hardship and health-related social needs (e.g., insecurity about food, housing, transportation, utilities) are common among patients with cancer, resulting in health disparities in cancer outcomes. Our study will test the efficacy of a multicomponent financial navigation and counseling program delivered by a financial navigator (CostCOM), vs. direct patient access to financial education materials and comprehensive list of local resources in the absence of a financial navigator (FinEd) vs. practice usual care among newly diagnosed cancer patients who screen positive for financial hardship and social needs. Investigators anticipate that both CostCOM and FinEd compared to enhanced usual care will improve cost-related cancer care nonadherence, financial worry, health insurance literacy, quality of life and sleep quality and decrease number of missed appointments.

Interventions

  • OTHER Usual care
  • BEHAVIORAL CostCOM (Cost Communication, Financial navigation and counseling)
  • BEHAVIORAL Provision of local and national resources to address financial and social needs
  • BEHAVIORAL Financial Education
  • OTHER Screening for financial and social needs

Study Locations (6)

California

  • UCI Health Cancer Center - Newport — Costa Mesa
  • UCI Health Chao Family Comprehensive Cancer Center - Fountain Valley — Fountain Valley
  • CHAO Family Comprehensive Cancer Center- Irvine — Irvine
  • UCI Health Chao Family Comprehensive Cancer Center - Laguna Hills — Laguna Hills
  • UCI Chao Family Comprehensive Cancer Center — Orange
  • UCI Health - Yorba Linda — Yorba Linda

Trial Details

FieldValue
Enrollment Target 91 participants
Start Date 2024-08-26
Est. Completion 2026-12-01
Phase NA

Sponsor

University of California, Irvine

353 total trials

Interested in This Trial?

Always speak with your doctor before enrolling in a clinical trial.

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06430840

The ClinicalTrials.gov registry entry for NCT06430840 describes a study currently listed as active not recruiting. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 91 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Irvine, which has 353 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.

The record links to 2 conditions, with Cancer appearing as the primary indexed condition, and to 5 interventions — of which Usual care is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.

Geographic footprint matters for practical reasons: NCT06430840 reports 6 study locations spanning 1 distinct geographic area — top geographies include California. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.

Frequently Asked Questions

What is clinical trial NCT06430840 about?

NCT06430840 is a clinical study titled "Addressing Financial and Social Needs Among Patients With Cancer". Financial hardship and health-related social needs (e.g., insecurity about food, housing, transportation, utilities) are common among patients with cancer, resulting in health disparities in cancer outcomes. Our study will test the efficacy of a multicomponent financial navigation and counseling pro...

What is the current status of trial NCT06430840?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 91 participants. The study started on 2024-08-26. Estimated completion is 2026-12-01.

What conditions does trial NCT06430840 study?

This clinical trial studies the following conditions: Cancer, Financial Hardship. These conditions were identified from the trial registry and reflect the primary focus areas of the research.

What interventions are being tested in trial NCT06430840?

The interventions under investigation include: Usual care (OTHER), CostCOM (Cost Communication, Financial navigation and counseling) (BEHAVIORAL), Provision of local and national resources to address financial and social needs (BEHAVIORAL), Financial Education (BEHAVIORAL), Screening for financial and social needs (OTHER). Each intervention is being evaluated for safety and efficacy as part of this clinical study.

Who is sponsoring clinical trial NCT06430840?

This trial is sponsored by University of California, Irvine, which has 353 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.

Where is trial NCT06430840 being conducted?

This trial has 6 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Related

Data sourced from official U.S. government datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial